Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE) by the PXE Reference Center at the CHU in Angers, France, Thanks to the Implementation of Alternating Pathways, Adapted to Age and Symptomatology, and Including Teleconsultations

NCT06636344 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT06636344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06636344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE) by the PXE Reference Center at the CHU in Angers, France, Thanks to the Implementation of Alternating Pathways, Adapted to Age and Symptomatology, and Including Teleconsultations
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Recruiting
Start date
February 9, 2026
Completion date
January 31, 2031
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pseudoxanthoma elasticum